FGEN Fibrogen Inc

FibroGen Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of novel therapeutics to treat serious unmet medical needs.

$13.16  -0.12 (-0.87%)
As of 07/26/2021 09:51:22 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  11/14/2014
Outstanding shares:  92,128,227
Average volume:  2,243,117
Market cap:   $1,256,629,016
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    31572Q808
ISIN:        US31572Q8087
Sedol:      BSDRYR8
Valuation   (See tab for details)
PE ratio:   -6.69
PB ratio:   3.29
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy